Approval Of New Medical Robot Raises Hope Of Better Surgeries

The approval of a new design of robot, to be used for intensive surgeries and medical utility, by the Food and Drug Administration has renewed hopes of better surgeries. The prototype, designed by Intuitive Surgical Inc., has received the nod of the USFDA after its’ older version was discarded, which has sent its’ shares plummeting to new high.
The company, which made its’ name by launching the da Vinci series of surgical robots, has launched the newest version called the da Vinci Xi. It has more utility, more functions, a larger range of movements and a better controlled navigation system. The doctor just have to operate the controls and the robots, which has been built using latest technology, itself assists in and performs surgeries.

The company’s future was doubtful as issues were raised regarding the reluctance of FDA to allow technology in the sphere of medicine. With this backdrop, the approval has come as a great boon for the entire medical fraternity, the company whose stocks have surged to record levels and the also skeptical shareholders.

The new robots ushers in a new era of application of machines in human healthcare. It has a selling price of 1.85 million dollars. With better precision, thinner arms and greater understandability, the robots can reach to a lot more areas in the body.

It still remains to be seen that whether the price and technology are attractive enough for the medical institutions to rely on. But this is a big breakthrough for science and for the company.